Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia

Blood. Volume 115, Issue 26: p.5312-5321, 4 February 2010, 10.1182/blood-2009-09-245944

Gene expression profiling of 207 uniformly treated children with high-risk B-progenitor acute lymphoblastic leukemia revealed 29 of 207 cases (14%) with markedly elevated expression of CRLF2 (cytokine receptor-like factor 2). Each of the 29 cases harbored a genomic rearrangement of CRLF2: 18 of 29 (62%) had a translocation of the immunoglobulin heavy chain gene IGH@ on 14q32 to CRLF2 in the pseudoautosomal region 1 of Xp22.3/Yp11.3, whereas 10 (34%) cases had a 320-kb interstitial deletion centromeric of CRLF2, resulting in a P2RY8-CRLF2 fusion. One case had both IGH@-CRLF2 and P2RY8-CRLF2, and another had a novel CRLF2 rearrangement. Only 2 of 29 cases were Down syndrome. CRLF2 rearrangements were significantly associated with activating mutations of JAK1 or JAK2, deletion or mutation of IKZF1, and Hispanic/Latino ethnicity (Fisher exact test, P < .001 for each). Within this cohort, patients with CRLF2 rearrangements had extremely poor treatment outcomes compared with those without CRLF2 rearrangements (35.3% vs 71.3% relapse-free survival at 4 years; P < .001). Together, these observations suggest that activation of CRLF2 expression, mutation of JAK kinases, and alterations of IKZF1 cooperate to promote B-cell leukemogenesis and identify these pathways as important therapeutic targets in this disease. Trial registration: ClinicalTrials.gov NCT00005603 (http://clinicaltrials.gov/show/NCT00005603).

Supplemental Data Files

• GDC Manifests
  • Controlled-Access Data Download Manifest (5 Files)
  • Open-Access Data Download Manifest (17 Files)

• Copy Number Array
  • TARGET ALL P1 Copy Number Array Level 1 Data (Controlled)
  • TARGET ALL P1 Copy Number Array Level 2 Data (Controlled)
  • TARGET ALL P1 Copy Number Array Level 3 Data
  • TARGET ALL P1 Copy Number Array Level 4 Data
  • TARGET ALL P1 Copy Number Array Metadata
• Gene Expression
  • TARGET ALL P1 Gene Expression Array Level 1 Data
  • TARGET ALL P1 Gene Expression Array Level 2 Data
  • TARGET ALL P1 Gene Expression Array Level 3 Data
  • TARGET ALL P1 Gene Expression Array Level 4 Data
  • TARGET ALL P1 Gene Expression Array Metadata
• mRNA-Seq
  • TARGET ALL P1 mRNA-seq Level 3 Data
  • TARGET ALL P1 mRNA-seq Level 3 Data (Controlled)
  • TARGET ALL P1 mRNA-seq Metadata
• Kinome
  • TARGET ALL P1 Kinome Metadata
  • TARGET ALL P1 Kinome Level 1 Data (Controlled)
• WGS
  • TARGET ALL P1 and P2 WGS L3 Data
  • TARGET ALL P1 and P2 WGS L3 Data (Controlled)
  • TARGET ALL P1 and P2 WGS L4 Data
  • TARGET ALL P1 and P2 WGS Metadata
• Additional Information
  • TARGET ALL P1 Sample Matrix
  • TARGET ALL P1 ID Mapping Information

Additional Resources

• TARGET ALL P1 at SRA (link is external) NCBI

Instructions for Data Download

Open Access Data

1. Download the appropriate manifest file from the publication page
2. Use the manifest file to download data using the GDC Data Transfer Tool (DTT) or the GDC API
   • GDC DTT (Download, User's Guide)
   • GDC API (User’s Guide)

Controlled Access Data

1. Download the appropriate manifest file from the publication page
2. Download a token from the GDC Data Portal
   • GDC Data Portal (Launch, User’s Guide)
3. Use the manifest file and token to download data using the GDC DTT or the GDC API
   • GDC DTT (Download, User’s Guide)
   • GDC API (User’s Guide)

For assistance, please contact the GDC Help Desk: support@nci-gdc.datacommons.io